Pub. Date : 2006 Jan
PMID : 16321828
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Especially the commercially available anti-CD20 antibody 90Y-ibritumomab tiuxetan is currently under investigation in various trials including dose escalation and autologous hematopoietic progenitor cell support. | ibritumomab tiuxetan | keratin 20 | Homo sapiens |